2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crawford, DK; Kumar, S; Mangiardi, M; Moore, S; Patel, R; Suwanna, N; Tiwari-Woodruff, SK | 1 |
Itoh, N; Khalaj, AJ; Kumar, S; Martinez-Torres, L; Moore, SM; Nakai, J; Tiwari-Woodruff, SK; Winchester, Z; Yoo, T; Yoon, J | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Multiple Sclerosis
Article | Year |
---|---|
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Topics: Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Calpain; Caspase 3; Corpus Callosum; Electrophysiological Phenomena; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor beta; Female; Immunohistochemistry; Ligands; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Multiple Sclerosis; Myelin Sheath; Nitriles; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Postural Balance; Selective Estrogen Receptor Modulators; Signal Transduction; Spinal Cord; TOR Serine-Threonine Kinases | 2013 |
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Topics: Animals; Cell Lineage; Estrogen Receptor beta; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Electron; Microscopy, Fluorescence; Multiple Sclerosis; Myelin Sheath; Nitriles; Oligodendroglia; Propionates; Spinal Cord | 2013 |